(202) 599-8435

FDA Plans To Finalize Guidance on Generic Abuse-Deterrent Opioids by End of Year

The U.S. Food & Drug Administration (FDA) expects to finalize guidance on the development of generic abuse-deterrent opioids (ADOs) by the end of 2017. However, the FDA says that further research is still needed to bring generic ADOs to the market. Read more here.

Print Friendly
About the Author